RxDoctor Payments Data

Sang Lee, MD

Colon & Rectal Surgery · Los Angeles, CANPI 1386651867

Payments from drug & device makers

What this record shows

This record is dominated by other: $2,274,810 of the $2,415,709 with a category attached, or 94.2%. Stryker accounts for 94.2% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $2,296,585, more than ten times the $46,542 reported in 2019. Among colon & rectal surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,415,709in general payments, 2019–2025

Across 198 payments — averaging $12,201 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2.3M
  • Olympus Corporation$39K
  • Boston Scientific$37K
  • Olympus Corporation Of The Americas$18K
  • Applied Medical Resources Corporation$17K
  • Guard Medical Inc.$11K
  • plus $19K from 19 others
$149,824in research payments, 2019–2025

Across 7 payments — averaging $21,403 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Fujifilm Healthcare Americas Corporation$116K
  • Takeda Pharmaceuticals U.S.A., Inc.$22K
  • Boston Scientific$13K

What the payments were for

  • Consulting fees$56,6442%
  • Speaking & faculty fees$38,8902%
  • Travel & lodging$20,5871%
  • Food & beverage$6,9930%
  • Education$17,7861%
  • Other$2,274,81094%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,415,709 in reported general payments places this provider in the 95th percentile of 176 colon & rectal surgery providers in California.

See all colon & rectal surgery providers in California

Medicare billing

Part B allowed, 2024
$108,302
Medicare patients
188
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate16$73
Metronidazole17$16

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →